DarioHealth Analyst Ratings
DarioHealth Analyst Ratings
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 30.16% | Alliance Global Partners | $5.45 → $4.1 | Maintains | Buy |
| 07/25/2023 | 90.48% | Stifel | $9 → $6 | Maintains | Buy |
| 05/12/2023 | 153.97% | Craig-Hallum | $14 → $8 | Maintains | Buy |
| 11/16/2022 | 138.1% | Alliance Global Partners | $9.15 → $7.5 | Maintains | Buy |
| 08/18/2022 | 376.19% | Aegis Capital | $20 → $15 | Maintains | Buy |
| 08/16/2022 | 344.44% | Cowen & Co. | $18 → $14 | Maintains | Outperform |
| 05/16/2022 | 534.92% | Aegis Capital | $23 → $20 | Maintains | Buy |
| 05/16/2022 | 471.43% | Cowen & Co. | $14 → $18 | Maintains | Outperform |
| 05/13/2022 | — | Alliance Global Partners | Upgrades | Neutral → Buy | |
| 01/26/2022 | 693.65% | Aegis Capital | $28 → $25 | Maintains | Buy |
| 08/19/2021 | 788.89% | Aegis Capital | $35 → $28 | Maintains | Buy |
| 04/22/2021 | 884.13% | Cowen & Co. | → $31 | Initiates Coverage On | → Outperform |
| 03/23/2021 | 852.38% | Stifel | → $30 | Initiates Coverage On | → Buy |
| 02/08/2021 | 1011.11% | Aegis Capital | $25 → $35 | Maintains | Buy |
| 08/17/2020 | 693.65% | Aegis Capital | → $25 | Initiates Coverage On | → Buy |
| 06/22/2020 | 217.46% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 05/13/2020 | 153.97% | Craig-Hallum | $7 → $8 | Maintains | Buy |
| 06/06/2019 | -52.38% | Craig-Hallum | → $1.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月11日 | 30.16% | 联盟全球合作伙伴 | $5.45→$4.1 | 维护 | 买 |
| 07/25/2023 | 90.48% | Stifel | $9→$6 | 维护 | 买 |
| 2023年05月12日 | 153.97% | 克雷格-哈勒姆 | $14→$8 | 维护 | 买 |
| 2022年11月16日 | 138.1% | 联盟全球合作伙伴 | $9.15→$7.5 | 维护 | 买 |
| 2022/08/18 | 376.19% | 宙斯盾资本 | $20→$15 | 维护 | 买 |
| 08/16/2022 | 344.44% | 考恩公司 | $18→$14 | 维护 | 跑赢大盘 |
| 05/16/2022 | 534.92% | 宙斯盾资本 | $23→$20 | 维护 | 买 |
| 05/16/2022 | 471.43% | 考恩公司 | $14→$18 | 维护 | 跑赢大盘 |
| 2022年05月13日 | - | 联盟全球合作伙伴 | 升级 | 中性→购买 | |
| 2022年01月26日 | 693.65% | 宙斯盾资本 | $28→$25 | 维护 | 买 |
| 2021/08/19 | 788.89% | 宙斯盾资本 | $35→$28 | 维护 | 买 |
| 04/22/2021 | 884.13% | 考恩公司 | →$31 | 开始承保 | →跑赢大盘 |
| 03/23/2021 | 852.38% | Stifel | →$30 | 开始承保 | →购买 |
| 02/08/2021 | 1011.11% | 宙斯盾资本 | $25→$35 | 维护 | 买 |
| 2020/08/17 | 693.65% | 宙斯盾资本 | →$25 | 开始承保 | →购买 |
| 06/22/2020 | 217.46% | ThinkEquity | →$10 | 开始承保 | →购买 |
| 2020/05/13 | 153.97% | 克雷格-哈勒姆 | $7→$8 | 维护 | 买 |
| 2019年06月06日 | -52.38% | 克雷格-哈勒姆 | →$1.5 | 开始承保 | →购买 |
What is the target price for DarioHealth (DRIO)?
DarioHealth的目标价是多少？
The latest price target for DarioHealth (NASDAQ: DRIO) was reported by Alliance Global Partners on August 11, 2023. The analyst firm set a price target for $4.10 expecting DRIO to rise to within 12 months (a possible 30.16% upside). 6 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2023年8月11日报道了DarioHealth(纳斯达克：DIO)的最新目标价。这家分析公司将目标价定为4.10美元，预计Drio将在12个月内上涨(可能上涨30.16%)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for DarioHealth (DRIO)?
分析师对DarioHealth的最新评级是多少？
The latest analyst rating for DarioHealth (NASDAQ: DRIO) was provided by Alliance Global Partners, and DarioHealth maintained their buy rating.
达里奥健康(纳斯达克代码：DIO)的最新分析师评级由联盟全球合作伙伴提供，达里奥健康维持买入评级。
When is the next analyst rating going to be posted or updated for DarioHealth (DRIO)?
DarioHealth的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DarioHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DarioHealth was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与DarioHealth的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。DarioHealth的上一次评级是在2023年8月11日提交的，所以你应该预计下一次评级将在2024年8月11日左右提供。
Is the Analyst Rating DarioHealth (DRIO) correct?
分析师对DarioHealth的评级正确吗？
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的DarioHealth(Drio)评级保持不变，目标价在5.45美元至4.10美元之间。DarioHealth目前的交易价格为3.15美元，超出了分析师的预测区间。